Outcome of Board Meeting

Q2FY27 results (unaudited): Standalone: Revenue 45.5bn +23% y-y (37.0bn) EBITDA 4.6bn +26% y-y (3.7bn) EBITDA margin 10.1% (13.7%) -360 bps y-y PAT 1.64bn +23% y-y (1.52bn) Consolidated: Revenue 47.6bn +26% y-y (37.7bn) EBITDA 4.52bn +27% y-y (3.56bn) EBITDA margin 9.5% (9.1%) +40 bps y-y PAT 1.12bn -37% y-y (1.78bn) Six months ended September 30, 2026 (unaudited): Standalone: Revenue 87.1bn +21% y-y (72.2bn) EBITDA 8.8bn +29% y-y (6.8bn) EBITDA margin 10.1% (9.4%) +70 bps y-y PAT 2.62bn -22% y-y (3.37bn) Consolidated: Revenue 90.8bn +24% y-y (73.1bn) EBITDA 8.9bn +26% y-y (7.1bn) EBITDA margin 9.8% (9.7%) +10 bps y-y PAT 2.98bn -39% y-y (4.89bn) Dividend: Not declared or recommended in this filing. Commentary: The company reported strong double-digit revenue growth led by premium segment growth despite raw material cost pressures from the West Asia crisis. Management expects continued double-digit growth and further price hikes in H2FY27, while maintaining fiscal discipline amid cost pressures and higher capital expenditure.